3 beaten-down ASX 200 stocks tipped to rocket over 100% higher 

Find out what the experts expect from these shares in 2026.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) reached a new all-time high on Wednesday. And while many big achievers helped drive the index to new highs, some beaten-down shares have moved in the opposite direction.

But not all of them will continue spiralling.

Here are three ASX 200 stocks that are expected to stage a turnaround this year. And some could climb as high as 100%, or even more.

Three businesspeople leap high with the CBD in the background.

Image source: Getty Images

Xero Ltd (ASX: XRO)

Xero shares were in the green on Wednesday afternoon, but the stock is still down nearly 60% over the past 12 months. 

The cloud-based accounting software company was caught up in the sector-wide tech sell-off and AI-related nervousness late last year (and into early 2026). This, combined with investor worry about the company's Melio acquisition, and potentially overvalued share price, saw many sell up. 

But Xero's business model, which is often referred to as "sticky",  has recurring revenue, global exposure, and profitability. It's actively expanding its presence and its product suite, too. 

I think there's a chance that the ASX 200 stock could double in value in 2026. Some analysts think it could storm even higher. Data shows the majority (12 out of 13) have a buy or strong buy rating on the stock with a maximum target price of $229.89 a piece. That implies a huge potential 204.98% upside at the time of writing.

Pro Medicus Ltd (ASX: PME)

Pro Medicus shares enjoyed a reprieve on Wednesday and closed in the green for the day. It comes off the back of a long string of declines due to similar sector-wide headwinds, which affected Xero stock.

Three of the company's directors have increased their existing stake by purchasing additional Pro Medicus shares, which raises a green flag for other investors. 

Out of 14 analysts, nine have a buy or strong buy rating on the stock. The average target price is $220.75, which implies a 91.57% upside at the time of writing. However, some think it could soar even higher to $300 a piece. That represents a potential 160.35% upside for Pro Medicus shares.

WiseTech Global Ltd (ASX: WTC)

WiseTech shares jumped over 10% after the company posted its half-year results on Wednesday morning. From an AFP and ASIC raise to a boardroom fallout, the logistics software company has sent WiseTech shares crashing over the past 8 months.

But investors are happy with the latest results announcement, suggesting that investor sentiment could finally be turning a corner for the beaten-down ASX 200 stock.

Most analysts already had a strong buy rating on the tech stock, with a maximum target price of $167.64 over the next 12 months. Even after Wednesday's rally, that implies a huge 253.23% upside for investors at the time of writing.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Growth Shares

2 of the best Aussie ASX 200 shares to buy and hold for 10 years

Two quality stocks with global growth runways and 40% to 100% potential upside.

Read more »

Green stock market graph.
Growth Shares

2 ASX 200 shares I rate as top buys for growth

I’m excited about the long term of these stocks.

Read more »

A man clenches his fists with glee having seen the share price go up on the computer screen in front of him.
Growth Shares

2 ASX 200 shares that turned a $5,000 investment into $10 million

These shares have generated enormous returns.

Read more »

A woman with a magnifying glass adjusts her glasses as she holds the glass to her computer screen and peers closely at it.
Growth Shares

3 ASX growth shares you'll wish you'd bought at these cheap prices

These high-quality growth businesses are now trading well below prior peaks.

Read more »

Person pointing finger on on an increasing graph which represents a rising share price.
Growth Shares

Experts rate these 2 ASX growth shares as buys this month!

These businesses are predicted to make double-digit returns.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Growth Shares

3 ASX 200 shares tipped to climb 130% (or more) in the next 12 months

Analysts are bullish about the outlook for these shares.

Read more »

A man in a suit looks surprised as he looks through binoculars.
Gold

This ASX stock soared 435% in 12 months, and is tipped to keep climbing

This ASX stock has hugely outperformed the ASX 300 over the past 12 months.

Read more »

Three excited business people cheer around a laptop in the office
Growth Shares

3 ASX 200 shares to buy and hold for a decade or more

If you’re building a 10-year portfolio, these ASX 200 stocks offer powerful structural tailwinds.

Read more »